The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

GSK GLAXOSMITHKLINE PLC ORD 25P



Income Statement 31-Dec-12
( £ m )
31-Dec-13
( £ m )
31-Dec-14
( £ m )
31-Dec-15
( £ m )
31-Dec-16
( £ m )
Continuing Operations
Revenue  26431.00 26505.00 23006.00 23923.00 27889.00
Operating Profit/(Loss)  7300.00 7028.00 3597.00 10322.00 2598.00
Net Interest  745.00 726.00 688.00 655.00 671.00
Profit Before Tax  6600.00 6647.00 2968.00 10526.00 1939.00
Profit After Tax  4678.00 5628.00 2831.00 8372.00 1062.00
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  4678.00 5628.00 2831.00 8372.00 1062.00
Attributable to:
Minority Interests  -179.00 -192.00 -75.00 50.00 -150.00
Equity Holders of Parent Company  4499.00 5436.00 2756.00 8422.00 912.00
 
Continuing EPS
Earnings per Share - Basic  91.60p 112.50p 57.30p 174.30p 18.80p
Earnings per Share - Diluted  90.20p 110.50p 56.70p 172.30p 18.60p
Earnings per Share - Adjusted  111.40p 108.40p 95.40p 75.70p 102.40p
Continuing and Discontinued EPS
Earnings per Share - Basic  91.60p 112.50p 57.30p 174.30p 18.80p
Earnings per Share - Diluted  90.20p 110.50p 56.70p 172.30p 18.60p
Earnings per Share - Adjusted  111.40p 108.40p 95.40p 75.70p 102.40p
 
Dividend per Share  72.00p 76.00p 80.00p 80.00p 80.00p

Balance Sheet 31-Dec-12
( £ m )
31-Dec-13
( £ m )
31-Dec-14
( £ m )
31-Dec-15
( £ m )
31-Dec-16
( £ m )
Assets
Non-Current Assets
Property, Plant & Equipment  6835.00 6355.00 6671.00 6998.00 7640.00
Intangible Assets  14520.00 13488.00 12044.00 21834.00 24741.00
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  1366.00 1525.00 1454.00 1462.00 1248.00
Other Financial Assets  54.00 1.00 0.00 0.00 0.00
Other Non-Current Assets  5014.00 5490.00 5804.00 6565.00 8741.00
  27789.00 26859.00 25973.00 36859.00 42370.00
Current Assets
Inventories  3969.00 3900.00 4231.00 4716.00 5102.00
Trade & Other Receivables  5345.00 5571.00 4738.00 5795.00 6252.00
Cash at Bank & in Hand  4184.00 5534.00 4338.00 5830.00 4897.00
Current Asset Investments  130.00 221.00 215.00 200.00 245.00
Other Current Assets  64.00 1.00 1156.00 46.00 215.00
  13692.00 15227.00 14678.00 16587.00 16711.00
 
Total Assets  41481.00 42086.00 40651.00 53446.00 59081.00
 
Liabilities
Current Liabilities
Borrowings  -3631.00 -2789.00 -2943.00 -1308.00 -4129.00
Other Current Liabilities  -10184.00 -10888.00 -10352.00 -12109.00 -14872.00
  -13815.00 -13677.00 -13295.00 -13417.00 -19001.00
 
Net Current Assets  -123.00 1550.00 1383.00 3170.00 -2290.00
 
Non-Current Liabilities
Borrowings  -14671.00 -15456.00 -15841.00 -15324.00 -14661.00
Provisions  -1703.00 -1245.00 -990.00 -1942.00 -2586.00
Other Non-Current Liabilities  -4555.00 -3896.00 -5589.00 -13885.00 -17870.00
  -20929.00 -20597.00 -22420.00 -31151.00 -35117.00
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -34744.00 -34274.00 -35715.00 -44568.00 -54118.00
 
Net Assets  6737.00 7812.00 4936.00 8878.00 4963.00
 
Capital & Reserves
Share Capital  1349.00 1336.00 1339.00 1340.00 1342.00
Share Premium Account  2022.00 2595.00 2759.00 2831.00 2954.00
Other Reserves  1787.00 2153.00 2239.00 2340.00 2220.00
Retained Earnings  642.00 913.00 -2074.00 -1397.00 -5392.00
Shareholders Funds  5800.00 6997.00 4263.00 5114.00 1124.00
 
Minority Interests/Other Equity  937.00 815.00 673.00 3764.00 3839.00
Total Equity  6737.00 7812.00 4936.00 8878.00 4963.00

Ratios - based on IFRS 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15 31-Dec-16
Continuing Operations
PE Ratio - Adjusted   11.98 14.87 14.42 18.14 15.25
PEG - Adjusted   1.84 -5.53 -1.20 -0.88 0.43
Earnings per Share Growth - Adjusted   6.50% -2.69% -11.99% -20.65% 35.27%
Dividend Cover  1.55 1.43 1.19 0.95 1.28
Revenue Per Share  538.09p 548.64p 478.49p 495.20p 573.85p
Pre-Tax Profit per Share  134.36p 137.59p 61.73p 217.88p 39.90p
Operating Margin  27.45% 28.34% 20.22% 55.09% 23.25%
Return on Capital Employed  47.87 % 46.07 % 23.07 % 126.38 % 45.89 %
 
Continuing & Discontinued Operations
Dividend Yield  5.39% 4.72% 5.81% 5.83% 5.12%
Dividend per Share Growth  7.46% 5.56% 5.26% 0.00% 0.00%
Net Asset Value per Share (exc. Intangibles)  -177.86p -133.70p -159.98p -343.34p -480.99p
Net Gearing  243.41% 181.66% 338.87% 211.22% 1236.03%

Data provided by Morningstar




Company Information
Updated Monthly
Company address C8 Gsk House, 980 Great West Road, Brentford, TW8 9GS, United Kingdom
Company website http://www.gsk.com
Market cap(in millions)* £ 73,958.18
Listing/Admission to trading 22 May 1972
Trading service SETS
Market Main Market
Listing category Premium Equity Commercial Companies
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
17-Aug-17
FTSE index FTSE All-Share,FTSE Eurotop 300,FTSE 350 High Yield,FTSE 100,FTSE 350 (ex IT),FTSE techMARK All-Share,FTSE All-Share (ex IT),FTSE 350
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment SET0
MiFID Status Regulated Market
Exchange market size 1,500
SEDOL 0925288
ISIN number GB0009252882



GLAXOSMITHKLINE share fundamentals (GSK)